Regenxbio stock price
리젠엑스바이오NASDAQ:RGNX · Nasdaq · HealthcareToday's signals · MACD bullish cross
Signal details →Regenxbio last closed at $7.43 (+0.13%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -2.0×. Its overall grade ranks 382 of 739 stocks in Healthcare.
About this company
Regenxbio last closed at $7.43 (+0.13%) on 2026-10-02. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 382/739
Valuation grade C
Related stocks
- NovartisCustomer
유전자치료제 파트너십 및 상업화 관련 핵심 고객/협력사
- Neurocrine BiosciencesCustomer
RGX-121 등 AAV 기반 유전자치료 공동개발/라이선스 파트너
- AbbVieCustomer
Regenxbio의 AAV 플랫폼을 활용한 협업 파트너
About Regenxbio
- What technical signals does Regenxbio (RGNX) have?
- Regenxbio current technical signals: MACD bullish cross.
- Is Regenxbio a cup-and-handle pattern?
- No. Regenxbio has no valid Cup signal right now.
- What published figures are available for Regenxbio?
- Market cap: $376.13M. Trailing 12 months PER: -2.0×. Latest quarter PBR: 5.49×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Regenxbio, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).